With the analysis among 131 patents, we discovered top 31 key players by total patent application. BioMarin Pharmaceutical, Inc., Institut National de la Santé et de la Recherche Médicale, Pfizer Inc. are dominant in this area. They take 66.41% of the total patent filing.
California, United States
Patent: 37
New York, United States
Patent: 19
Connecticut, United States
Patent: 14
Hovedstaden, Denmark
Patent: 7
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 3
With the analysis among 49 patents, we discovered top 2 start-ups by total patent application.
California, United States
Patent: 1
With the analysis among related 34 patents applied in the last 5 years. We discover 24 most active companies in this area. The fast-growing Institut National de la Santé et de la Recherche Médicale, Université Côte dAzur, Pfizer Inc. take 97.06% of patent filing during this period.
New York, United States
Patent: 7
California, United States
Patent: 2
Indiana, United States
Patent: 2
With the analysis among related 34 patents in last 5 years, we discover 10 new entrants. Eli Lilly & Co., Université de Paris, Beijing Jishuitan Hospital are the most active new entrants in this area.
Indiana, United States
Patent: 2
Beijing Shi, China
Patent: 1
Nordrhein-Westfalen, Germany
Patent: 1
Beijing Shi, China
Patent: 1
Guangdong Sheng, China
Patent: 1
California, United States
Patent: 1
Guangdong Sheng, China
Patent: 1
Connecticut, United States
Patent: 1
With the analysis among 87 patents, we discovered top 13 universities and scientific research institutions by total patent application. Université Toulouse III - Paul Sabatier, Université Côte dAzur, Vanderbilt University are dominant in this area. They take 111.49% of the total patent filing.
Tennessee, United States
Patent: 11
Aichi-ken, Japan
Patent: 7
Connecticut, United States
Patent: 1
Chongqing Shi, China
Patent: 1